Balazs Halmos, MD, answers questions for him sent in to OncLive's social media accounts on Twitter, LinkedIn, and Instagram.
Ask Me Anything
Advertisement
Joshua Richter, MD, answers questions for him sent in to OncLive's social media accounts on Twitter, LinkedIn, Instagram, and Facebook.
Maurie Markman, MD, answers questions for him sent in to OncLive's social media accounts on Twitter, LinkedIn, Instagram, and Facebook.
Advertisement
Advertisement
Trending on OncLive
1
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ESMO 2026
2
TP53 Comutations, Long-Term Toxicity, and Sunvozertinib Access Shape EGFR+ NSCLC Treatment Decisions
3
Phase 1 Study of BGB-B2033 (GPC3 x 4-1BB Bispecific Antibody) Monotherapy: First Disclosure of Dose Optimization and Dose Escalation Update in Advanced Hepatocellular Carcinoma
4
Tocilizumab Prophylaxis, Caregiver Readiness, and Chair Time Shape Community Bispecific Programs in R/R Myeloma
5